Translator

50 Days To Mt. Kilimanjaro – Exercise & Cognitive Function In Parkinson’s Disease

By Pamela, on May 14th, 2011%

There was more exciting news this week on the positive benefits of exercise in Parkinson’s patients involving improved cognitive functions. This study was a subject highlighted at the annual meeting of the American Academy of Neurology. This study further illustrates why exercise should be included in the daily regimen for PD patients.

Just a few days ago, I published another article on the benefits of exercise that focused on improvement in mobility and balance. The combination of these two studies surely must send a powerful message to physicians and patients as they determine a course of treatment for those diagnosed . . . → Read More: 50 Days To Mt. Kilimanjaro – Exercise & Cognitive Function In Parkinson’s Disease

Leave a comment   Uncategorized   , , , , ,  

130 Days To Mt. Kilimanjaro – Vote Your Choice In The Neuro Film Festival

By Pamela, on February 23rd, 2011%

One in six Americans is affected by a brain disorder such as Alzheimer’s disease, migraine, autism, MS, Parkinson’s disease, epilepsy, ALS, stroke, and so many more. In total, there are more than 250 different disorders of the brain, many that I have never heard of, many that have no current medical trials researching their cure. In an effort to raise awareness for brain disorders and to raise valuable funds for more brain research, the American Academy of Neurology is hosting their second film festival which communicates the life stories of those suffering from many of these complex brain disorders. The winner of . . . → Read More: 130 Days To Mt. Kilimanjaro – Vote Your Choice In The Neuro Film Festival

Leave a comment   Uncategorized   , , , , , , , , , , , , , ,  

214 Days To Mt. Kilimanjaro – Parkinson’s Disease Quality Measures Created For Neurologist

By Pamela, on December 1st, 2010%

An article printed by the American Academy of Neurology (AAN) on November 29, 2010 reports a new measurement tool developed by the AAN for use by their members (other neurologist) in caring for patients with Parkinson’s disease.

This 10-point measurement tool is the first measurement ever developed by the AAN and I am pleased that they saw a need in establishing performance initiatives for Parkinson’s disease. Unlike many other diseases, there is little data collected and shared on Parkinson’s disease. This measurement tool will provide additional information relative to the progression of the disease, how patients are reacting to . . . → Read More: 214 Days To Mt. Kilimanjaro – Parkinson’s Disease Quality Measures Created For Neurologist

Leave a comment   Uncategorized   , , , ,